From: Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
 | Q1 | Q2 | Q3 | Q4 | P trend |
---|---|---|---|---|---|
ICAM-1 | |||||
 N cases/N | 21/597 | 41/589 | 59/571 | 101/582 |  |
 Model 1 | 1.00 | 1.73 (1.02–2.93) | 2.28 (1.37–3.78) | 3.20 (1.94–5.27) | <0.0001 |
 Model 2 | 1.00 | 1.47 (0.87–2.51) | 1.73 (1.03–2.91) | 1.94 (1.14–3.31) | 0.11 |
 Model 3 | 1.00 | 1.37 (0.81–2.34) | 1.56 (0.92–2.62) | 1.72 (1.01–2.94) | 0.07 |
 Model 4 | 1.00 | 1.31 (0.77–2.25) | 1.50 (0.89–2.52) | 1.64 (0.96–2.81) | 0.20 |
E-selectin | |||||
 N cases/N | 28/591 | 32/580 | 61/583 | 101/585 |  |
 Model 1 | 1.00 | 0.99 (0.59–1.65) | 1.69 (1.07–2.66) | 2.48 (1.60–3.85) | <0.0001 |
 Model 2 | 1.00 | 1.00 (0.59–1.68) | 1.56 (0.97–2.49) | 2.10 (1.31–3.38) | <0.0001 |
 Model 3 | 1.00 | 1.01 (0.60–1.69) | 1.34 (0.84–2.15) | 1.76 (1.09–2.83) | 0.0008 |
 Model 4 | 1.00 | 0.99 (0.59–1.67) | 1.30 (0.81–2.09) | 1.68 (1.04–2.71) | 0.0016 |
P-selectin | |||||
 N cases/N | 41/575 | 42/590 | 67/592 | 70/574 |  |
 Model 1 | 1.00 | 0.92 (0.59–1.41) | 1.38 (0.93–2.06) | 1.48 (0.98–2.22) | 0.097 |
 Model 2 | 1.00 | 0.76 (0.68–1.54) | 1.02 (0.68–1.54) | 0.93 (0.60–1.43) | 0.58 |
 Model 3 | 1.00 | 0.78 (0.50–1.22) | 0.96 (0.64–1.45) | 0.89 (0.58–1.37) | 0.49 |
 Model 4 | 1.00 | 0.78 (0.50–1.21) | 0.93 (0.62–1.41) | 0.80 (0.52–1.24) | 0.32 |
VCAM | |||||
 N cases/N | 58/489 | 56/497 | 42/502 | 30/494 |  |
 Model 1 | 1.00 | 1.14 (0.79–1.66) | 0.86 (0.57–1.29) | 0.75 (0.47–1.19) | 0.30 |
 Model 2 | 1.00 | 1.16 (0.80–1.69) | 0.87 (0.58–1.32) | 0.71 (0.43–1.15 | 0.09 |
 Model 3 | 1.00 | 1.09 (0.75–1.59) | 0.89 (0.59–1.34) | 0.78 (0.48–1.29) | 0.28 |
 Model 4 | 1.00 | 1.04 (0.71–1.52) | 0.85 (0.56–1.28) | 0.83 (0.51–1.38) | 0.31 |